Prevalence and risk factors for metabolic syndrome in schizophrenia, schizoaffective, and bipolar disorder
CONCLUSION: Our study found that around one in three patients had MetS irrespective of the three diagnoses. Some variables were significant predictors for MetS. Our findings were consistent with other studies and warrant the need for regular screening and management of abnormal metabolic parameters.Key pointsThere is no statistical difference between schizophrenia, schizoaffective disorder, and bipolar disorder with regards to the prevalence of metabolic syndrome.Fasting blood glucose levels and abnormally elevated triglycerides were significant predictors of metabolic syndrome.Screening of metabolic parameters is important as well as the careful tailoring of the choice of antipsychotics.PMID:38329470 | DOI:10.1080/13651501.2024.2310847
Source: International Journal of Psychiatry in Clinical Practice - Category: Psychiatry Authors: Hind Mohd Ahmed Karim Abdel Aziz Abeer Al Ammari Mohammed Galadari Aaisha Alsaadi Aysha Alhassani Fatima Al Marzooqi Mohammed AlAhbabi Hind Alsheryani Meera Bahayan Reem Ahmed Sara Alameri Emmanuel Stip Dina Aly El-Gabry Source Type: research
More News: Bipolar | Cardiology | Cardiovascular | Cholesterol | Endocrinology | Heart | Mania | Metabolic Syndrome | Middle East Health | Psychiatry | Schizophrenia | Statistics | Study | UAE Health